Literature DB >> 32438985

Evaluation and Management of Nonculprit Lesions in STEMI.

Troels Thim1, Nina W van der Hoeven2, Carmine Musto3, Robin Nijveldt4, Matthias Götberg5, Thomas Engstrøm6, Pieter C Smits7, Keith G Oldroyd8, Anthony H Gershlick9, Javier Escaned10, Sergio Bravo Baptista11, Luis Raposo12, Niels van Royen4, Michael Maeng13.   

Abstract

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CFR; FFR; STEMI; iFR; nonculprit coronary lesions

Mesh：

Year:  2020        PMID： 32438985     DOI： 10.1016/j.jcin.2020.02.030

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


  7 in total

Review 1.  FLOWER-MI and the root of the problem with non-culprit revascularisation.

Authors:  Matthew E Li Kam Wa; Kalpa De Silva; Carlos Collet; Divaka Perera
Journal:  Open Heart       Date:  2021-11

2.  Efficacy of Buqi Huoxue Decoction Combined with Cardiac Rehabilitation Nursing after Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction and Its Influence on Prognosis.

Authors:  Haiping Du; Hui Fu; Jing Yu; Zuowang Cheng; Yanhong Zhang
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

3.  Impact of COVID-19 pandemic on the management of nonculprit lesions in patients presenting with ST-elevation myocardial infarction: Outcomes from the pan-London heart attack centers.

Authors:  Ozan M Demir; Callum D Little; Richard Jabbour; Haseeb Rahman; Max Sayers; Asrar Ahmed; Michelle J Connolly; Ritesh Kanyal; Philip MacCarthy; Simon J Wilson; Miles Dalby; Ajay Jain; Iqbal Malik; Roby Rakhit; Divaka Perera
Journal:  Catheter Cardiovasc Interv       Date:  2021-12-30       Impact factor: 2.585

4.  Evaluation of Non-infarct-Related Arteries Using C-11 Acetate PET in STEMI With Multivessel Disease.

Authors:  Sang-Geon Cho; Minchul Kim; Seung Hun Lee; Ki Seong Park; Jahae Kim; Jang Bae Moon; Ho-Chun Song
Journal:  J Cardiovasc Imaging       Date:  2022-07

5.  Ischemic postconditioning protects nonculprit coronary arteries against ischemia-reperfusion injury via downregulating miR-92a, miR-328 and miR-494.

Authors:  Jian Wang; Wu Wang; Chengying Yan; Tianzhen Wang
Journal:  Aging (Albany NY)       Date:  2022-03-23       Impact factor: 5.682

6.  Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy).

Authors:  Troels Thim; Matthias Götberg; Ole Fröbert; Robin Nijveldt; Niels van Royen; Sergio Bravo Baptista; Sasha Koul; Thomas Kellerth; Hans Erik Bøtker; Christian Juhl Terkelsen; Evald Høj Christiansen; Lars Jakobsen; Steen Dalby Kristensen; Michael Maeng
Journal:  BMC Res Notes       Date:  2020-09-01

7.  Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study.

Authors:  Jan-Quinten Mol; Anouar Belkacemi; Rick Hja Volleberg; Martijn Meuwissen; Alexey V Protopopov; Peep Laanmets; Oleg V Krestyaninov; Robert Dennert; Rohit M Oemrawsingh; Jan-Peter van Kuijk; Karin Arkenbout; Dirk J van der Heijden; Saman Rasoul; Erik Lipsic; Steven Teerenstra; Cyril Camaro; Peter Damman; Maarten Ah van Leeuwen; Robert-Jan van Geuns; Niels van Royen
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.